Comment Re:Worst idea ever. (Well, one of them). (Score 3, Interesting) 168
I think he means we should restructure our health system in such a way that there is no big pharma or at least so that the size of the company offers no advantage. We need some major reforms in healthcare here in the states. With most of it being run by non-profits or at least a viable and equally competitive path being run by non-profits. This is true for all tech development.
Either way, there SHOULD be federal support for this, but only in the sense of loans from the federal reserve at the same rates and terms given to banks. This kind of development is of clear targeted benefit to our society in a far more obvious way than lining the pockets of wealthy bankers.
Let's say I'm someone who is capable of producing a drug or thinks I am. I should be able to use the local biology lab (akin to a library, either private non-profit or city sponsored) to develop it and perform the research I need. I should of course have to pay for access and when I submit a request for new equipment, whether or not to acquire that equipment should be a question posed to the existing membership along with how much it will increase dues and how long it's expected to increase them. Of course, I should always have the option of donating equipment myself. All members must be human persons (including partnerships) or non-profits (with no management salaries in top 10% income brackets). The requirement is that if developed further you must use "in system" facilities for manufacture and distribution and the lab will own the ip and all profits after costs will go to the inventor or non-profit that developed the drug but other members would be able to utilize the IP royalty free. Everyone is assigned a development log for every project and everything they do, every piece of equipment they use goes in and results are logged there. Including anything they do on their own without using lab equipment.
Trials and testing and advertising for the same. The same kind of thing. Centralize the costs but require those using the system to pay the costs. Streamline the process to parallel FDA approval and go through FDA approval using template requests and submissions. Members pay dues while using the process. The previous log is required and access is only to individuals and non-profits. Members vote on whether to proceed on studies and any study that hasn't met the minimum requirements for their study (animal trials on X subjects for Y time for instance) can't have it put to a vote unless they submit for an exemption and provide justification.
Manufacture, Advertising, sales, and distribution. This would need to be a national non-profit. Drugs would be sold with a fixed markup over a fair estimate of costs (30% is typical markup in a retailer). When patents expire drugs would continue to be made available at cost only without the markup as long as they are viable. If a capacity increase is needed or better equipment of some type, it goes to a vote of members with patents in the system. Want to pull a drug? It goes to a vote among the members of the system.
In the end, it costs what it costs and those costs are spread out among everyone developing drugs and those people get all the profits. Since all costs come from federal loans it's very easy to determine them. Divide up the total loan payment among the total number of mg/ml of drug produced and let the more expensive vs less expensive to produce drugs live with the average. It's better than all the min/maxing and duplicate charging games that result from any other way.
Either way, there SHOULD be federal support for this, but only in the sense of loans from the federal reserve at the same rates and terms given to banks. This kind of development is of clear targeted benefit to our society in a far more obvious way than lining the pockets of wealthy bankers.
Let's say I'm someone who is capable of producing a drug or thinks I am. I should be able to use the local biology lab (akin to a library, either private non-profit or city sponsored) to develop it and perform the research I need. I should of course have to pay for access and when I submit a request for new equipment, whether or not to acquire that equipment should be a question posed to the existing membership along with how much it will increase dues and how long it's expected to increase them. Of course, I should always have the option of donating equipment myself. All members must be human persons (including partnerships) or non-profits (with no management salaries in top 10% income brackets). The requirement is that if developed further you must use "in system" facilities for manufacture and distribution and the lab will own the ip and all profits after costs will go to the inventor or non-profit that developed the drug but other members would be able to utilize the IP royalty free. Everyone is assigned a development log for every project and everything they do, every piece of equipment they use goes in and results are logged there. Including anything they do on their own without using lab equipment.
Trials and testing and advertising for the same. The same kind of thing. Centralize the costs but require those using the system to pay the costs. Streamline the process to parallel FDA approval and go through FDA approval using template requests and submissions. Members pay dues while using the process. The previous log is required and access is only to individuals and non-profits. Members vote on whether to proceed on studies and any study that hasn't met the minimum requirements for their study (animal trials on X subjects for Y time for instance) can't have it put to a vote unless they submit for an exemption and provide justification.
Manufacture, Advertising, sales, and distribution. This would need to be a national non-profit. Drugs would be sold with a fixed markup over a fair estimate of costs (30% is typical markup in a retailer). When patents expire drugs would continue to be made available at cost only without the markup as long as they are viable. If a capacity increase is needed or better equipment of some type, it goes to a vote of members with patents in the system. Want to pull a drug? It goes to a vote among the members of the system.
In the end, it costs what it costs and those costs are spread out among everyone developing drugs and those people get all the profits. Since all costs come from federal loans it's very easy to determine them. Divide up the total loan payment among the total number of mg/ml of drug produced and let the more expensive vs less expensive to produce drugs live with the average. It's better than all the min/maxing and duplicate charging games that result from any other way.